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Abstract 
Cancer is an ongoing problem all over the world. To find a cure to this disease, both 
clinicians and scientists are looking for a reasonable treatment method. According to 
Hanahan and Weinberg, one of the hallmarks of cancer is evasion of programmed cell death, 
referred to as apoptosis. Apoptosis is an important cellular process, and is regulated by many 
different pathways. Proteins in these pathways contribute to either cell death or cell survival 
depending on the cell stresses. Much research in systems biology has been devoted to 
understanding these pathways at the molecular level.  
In this study a mathematical model is built to describe apoptosis, and the pathways 
involving the related proteins p53 and Akt. The primary purpose of the construction of the 
kinetic model is to verify that this network can exhibit bistability between cell survival and 
cell death. Sensitivity and bifurcation analysis are conducted to determine which parameters 
have the greatest effect on the system behavior.  
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Chapter 1 
Introduction 
1.1 Cancer 
Cancer is an ongoing worldwide problem for human health, despite intensive 
investigations by both clinicians and scientists who are trying to determine its underlying causes. 
As a disease, cancer is caused by accumulations of genetic mutations in the cell. The main 
characteristics of cancer were comprehensively described by Hanahan and Weinberg in “The 
Hallmarks of Cancer” [1]. According to their widely accepted classification, a cancer cell has the 
properties of: evading cell death, producing its own growth signals, disregarding antigrowth 
signals, replicating an unlimited number of times, promoting the formation of new blood cells, 
and invading through the surrounding tissues to induce secondary cancer.  
 In this study, the problem of cancer will be considered from a biomolecular basis by 
considering the means by which cancer cells are able to evade programmed cell death (called 
apoptosis). From this starting point, some important networks and their regulatory proteins 
introduced in Chapter 2 are examined in order to explore their relationship in the regulation of 
programmed cell death pathways. These proteins are involved in an intracellular signal 
transduction network that is responsible for regulating programmed cell death.  
 
1.2 Systems Biology 
Systems biology is a new biological field that focuses on a systems-level understanding 
of biological processes, including aspects of regulation. Building on the remarkable progress in 
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molecular biology, the systems biology approach can be used to develop predictive models based 
on an understanding of the structure and dynamics of molecular interactions within a network 
[2]. The goal of systems biology is to map complex biological pathways by considering the 
regulation of the components of the system, and to point out how these interactions affect the 
function and behavior of the system [3]. As a result, systems biology yields a holistic approach to 
biological research, which can be extended to cells, tissues and organisms [4].  
 
1.3 Cell Signaling Networks 
Our knowledge of cell signaling networks begins with interactions maps (sometimes 
called cartoon diagrams) that indicate protein-protein interactions and map their upstream and 
downstream reaction networks. These networks commonly have well-defined inputs and outputs, 
and are characterized by feedback loops, and multi-step regulatory controls. Due to the 
complexity of their structure and function, mathematical modeling has been needed to consider 
the system behavior of signaling networks [5].  
 
1.4 Mathematical Models 
Mathematical models complement experimental studies of real world problems in 
engineering, the life, social, and environmental sciences [6, 7]. Due to the complexity and 
nonlinearity of real world problem, it is often difficult to understand the role of each component 
in the behavior of a network. Mathematical modeling can be used to describe system dynamics, 
and better understand how network structure is related to system behavior [8]. Mathematical 
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models allow both the theoretical analysis of the system and the predictions of the results of 
experiments (see Figure 1.1).  
      
Figure 1.1: Representation of mathematical modeling  
 
1.5 Bistability 
A key feature of many cell signaling networks is bistability, which is the property of 
having two different stable steady states. In a cellular setting, bistability can arise from a strong 
positive feedback loop. For instance, if protein A activates protein B, and in turn protein B 
activates protein A (or likewise, if each inactivates the other) the system may show bistability 
[9]. In this study, bistability will correspond to two cell fates: cell survival or cell death. 
 
1.6 The Objective of the Presented Study 
Cancer develops from the molecular state of damaged cells, and one of the properties of 
the cancer is the evasion of cell death-signals. The aim of this research is to build a mathematical 
Real problem 
 Mathematical Model  Predictions 
formulate 
solve 
evaluate 
Real results 
validate 
hypothesize  
 Mathematical result  
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model that describes the network responsible for regulating programmed cell death, and to verify 
conditions under which this network exhibits bistability.   
To accomplish this goal, this thesis presents both biological and mathematical 
background on the mechanism and dynamics of cellular signaling pathways. For the biological 
background, related cell signaling pathways are examined in Chapter 2. Subsequently, 
mathematical background information is introduced in Chapter 3. This includes the techniques 
that are used to describe the pathways and the analysis that is used to investigate bistability. 
Chapter 4 describes a new model, which builds, in part, on previously published studies. 
Analysis of the model is presented in Chapter 4 with the discussion. Finally, concluding remarks 
and future directions are given in Chapter 5.  
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Chapter 2 
Biological Background 
2.1 Introduction 
In this chapter, three intertwined signalling networks will be described. In describing 
these pathways, only the key proteins will be introduced. This description follows the network 
models presented by Legewie et al. [10] and Aguda et al. [11].  
 
2.2 Apoptosis  
Cells are the basic structural and functional unit of all living things. Cell death can be 
caused by injury, but can also be the result of programmed molecular interactions (the absence of 
growth factors or the presence of death signals on the cell surface). Because these interactions 
are systematically regulated by the organism, this mode of cell death is called programmed cell 
death [12]. Apoptosis is the best-understood programmed cell death process (and indeed, these 
two terms are sometimes used interchangeably) [13]. Apoptosis is the Greek word for the falling 
of leaves from trees; the term was introduced to biology in 1972 by Kerr, Wylie, and Curries 
[14]. 
 
2.2.1 The Importance of Apoptosis 
Apoptosis is a homeostatic mechanism; it provides a means for organisms to eliminate 
abnormal or undesirable cells. For example, during the development of a human embryo, cells 
that link the fingers are killed via apoptosis to allow proper separation of the digits. Furthermore, 
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apoptosis functions as a quality control service or defense mechanism by eliminating damaged 
cells. For instance, when DNA damage occurs in the cell, the damaged cells normally undergo 
apoptosis to prevent their growth. Moreover, apoptosis occurs to maintain the cell population in 
developing tissues. Unlike the normal cells, cancer cells evade this cell death pathway by a 
number of mechanisms. From a clinical perspective, some chemotherapeutic drugs trigger the 
apoptotic pathway, allowing the targeting of neoplastic disorders such as cancer [15].   
 
2.2.2 The Biochemistry of Apoptosis 
2.2.2.1 Caspases 
Caspases, which are enzymes, are key components of the apoptotic signaling pathway; 
cell death starts with the activation of caspases. Caspases lead to apoptosis by cleaving proteins 
into small peptide molecules. The classification of cell death is defined in terms of caspase 
activity [16].  
Ten major caspases are classified as initiators (caspase-2, 8, 9, 10); which trigger 
caspase signaling cascade; inflammatory (caspase- 1, 4, 5); which trigger inflammation; and 
effectors or executioners (caspase-3, 6, 7); which are the agents of cell death, during apoptosis 
[16]. In this study, we will consider a network that includes two initiator caspases (8 and 9) and 
one effector caspase (3). 
 
2.2.3 Apoptotic Pathways 
Apoptosis is a highly regulated and controlled process. Apoptosis is fundamentally 
initiated through two distinct signaling networks: the extrinsic pathway and the intrinsic 
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pathway. Despite having an equivalent outcome (i.e., cell death), the initial points of these 
signaling pathways are different, as we next describe. 
2.2.3.1 Extrinsic Apoptotic Pathway 
The extrinsic pathway is induced from death receptors, which are placed on the cell 
surface. Death receptors are activated by extracellular death signals; when activated, they recruit 
and trigger initiator caspases 8 and 10. Subsequently, these activated initiator caspases activate 
the effector caspases 3 and 7 [15].  
2.2.3.2 Intrinsic Apoptotic Pathway 
The intrinsic pathway is triggered by cell stresses, such as DNA damage or loss of cell 
survival factors, such as oxygen or nutrients. The main characteristic of the intrinsic pathway is 
the deformation of the mitochondria, which causes release of the protein cytochrome-c from the 
mitochondria, triggering initiator and subsequently effector caspases [15].  
 
2.3 p53 and Akt/PKB Pathways 
Because of the importance of apoptosis in the regulation of cellular functions, scientists 
have been investigating other important cell signaling transduction network’s impact on the 
apoptotic pathways. In this study, we will consider two other important pathways: p53 and 
Akt/PKB.   
The p53 pathway involves a network of genes and their protein products. The activation 
of the p53 pathway is initiated by a variety of extrinsic and intrinsic stress signals, such as DNA 
damage, the lack of oxygen and nutrients. This pathway is regulated by positive and negative 
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autoregulatory feedback loops. The activity of the p53 pathways can lead to either cell cycle 
arrest or apoptosis [17].   
Another important signal transduction pathway for the regulation of cell functions is the 
Akt/PKB signaling pathway. This pathway is activated in response to growth signals. The main 
contributions of the Akt/PKB pathway to the cellular functions involve nutrient metabolism, cell 
growth, transcriptional regulation and cell survival [18]. In this study, the Akt/PKB signaling 
pathway will be considered in not only regulating cell survival but also in blocking apoptosis.  
Having mentioned the primary roles of these two pathways, we next consider proteins 
involved in the regulation of pathway behavior. In the p53 pathway, an autoregulatory feedback 
loop is provided via the interactions between p53 and the protein Mdm2, which inhibits p53 
activity [19]. 
p53 is known as “the guardian of the genome” because it prevents the growth of cells that 
suffer DNA damage [20]. When DNA damage occurs, p53 induce cell growth arrest or apoptosis 
depending on the cell type and the stress, and the action of p53 co- activators [20]. Thus, p53 
functions as a tumor suppressor gene, which functions to inhibit damaged cells from 
proliferation. As a result, p53 provides cell integrity; approximately 50% of human cancers 
involve a mutation in the p53 gene, and in particular 70% of colon cancers show p53 gene 
mutations [20].  
Mdm2 is the main regulator oncoprotein of p53. The regulation of these two proteins is 
maintained by a negative feedback loop. After the phosphorylation of Mdm2, phosphorylated 
Mdm2, which is denoted as Mdm2p in this study, migrates from the cytosol to the nucleus from 
where it inhibits p53’s activities. However, under cell stress, p53 activates either cell cycle repair 
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progression or a cell death signaling pathway. This cell cycle repair is initiated by mdm2 gene, 
which is activated by p53. Thus, the purpose of the negative feedback loops between Mdm2 and 
p53 is to keep p53 in the low concentration to prevent cell cycle arrest or apoptosis in the 
absence of cell stress. The direct regulation of p53 via Mdm2 suggests Mdm2 as a direct target of 
cancer treatment [21]. 
Unlike the p53-Mdm2 negative feedback loop, PTEN forms a positive feedback loop 
with p53 protein in the p53 pathway. PTEN is a tumor suppressor protein, and is activated via 
p53 protein after cell stresses. On the other hand, the role of PTEN on p53 activity is as follows. 
PTEN has a function to inhibit Akt/PKB signaling pathway. In normal conditions, Akt/PKB 
pathway provides the phosphorylation of Mdm2 via phosphorylated Akt (Aktp), and translocates 
it from cytoplasm to nucleus. Mdm2p in the nucleus keeps p53 concentration level low to inhibit 
unwanted cell death or cell cycle arrest. Thus, the inhibition of Akt/PKB signaling pathways via 
PTEN results in the blockage of the entrance of the phosphorylated Mdm2 into the nucleus. As a 
result, PTEN indirectly modulates p53 protein level in the nucleus upwards in order to activate 
programmed cell death [for review 22, 23, 24, 25].  
Thus, taking p53 and Akt/PKB signal transduction pathways together, we see that p53 
and PTEN are pro-apoptotic (or tumor suppressor) proteins because they trigger the cell to 
undergo apoptosis, while, Mdm2 and Akt are anti-apoptotic (oncoproteins) because they prevent 
programmed cell death by inhibiting the activity of pro-apoptotic proteins. 
In this study, we will address the interaction of p53-Akt/PKB network and apoptotic 
pathway.  
  10 
The Akt/PKB signaling pathway affects the apoptotic pathways process in a number of 
ways. In this study, we will focus on the inhibitory effect of Akt/PKB on apoptosis via activation 
of phosphorylated XIAP (XIAPp), which inhibits cell death, and inhibition of activated caspase3 
(casp3a) [26]. The p53 signaling pathway plays an opposite role in terms of the activation of 
apoptotic pathway. The detailed regulation of these pathways with apoptosis will be discussed in 
Chapter 4. 
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Chapter 3 
Dynamical Networks 
3.1 Introduction 
The cell is the primary structural and functional unit of all living organisms. Cells use 
their structure to accomplish a range of functions, such as migration, and sending and receiving 
signals. The purpose of this chapter is to introduce a mathematical representation of biochemical 
reaction networks within the cell, based on descriptions of reaction rates. The law of mass action 
will be used as a starting point for describing enzyme kinetics, which will be used to describe 
protein degradation, phosphorylation, dephosphorylation, expression, activation, inactivation, 
complex formation and complex dissociation. A kinetic description of protein production will be 
provided as well.  
Dynamical analysis of chemical networks will be considered as a second part of this 
chapter.  
3.2 A Description of Chemical Reaction Networks 
Before moving into the mathematical descriptions of chemical reactions, it is worthwhile 
to discuss the structure of chemical networks.  
Chemical reaction networks consist of molecular species and reactions among them 
(specified in a figure as arrows). Molecular species could be ions, small molecules, or molecular 
complexes. Reactions among species include chemical production or degradation, reaction 
catalysis, and promotion or inhibition of activity. These processes cause production, 
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interconversion, and consumption in the network. Thus, the amount of each species changes over 
time [27].  
As an illustration, consider the set of reactions shown below. 
                                      
Figure 3.1: Chemical reaction networks 
 
In Figure 3.1, A, B, C, and D are the molecular species. As an example, A and B is called 
the reactant, while, C is referred as product of the irreversible reaction 
3.3  Dynamic Behavior of Chemical Reaction Networks 
To describe the dynamics of the network, the reaction rates must be known. To arrive at 
reaction rates, it is firstly assumed that the reaction volume is well-mixed (i.e. molecules are 
present everywhere homogeneously).  Secondly, it is assumed that there is a great many reactant 
molecules [27].  These assumptions were made to introduce the law of mass action in the 
following section:  
𝐴                         
        𝐴                                  
𝐴 + 𝐵   𝐶  
 𝐴 + 𝐴 𝐷    
Production Reaction    :  
Degradation Reaction  :   
Irreversible Reaction   : 
Reversible Reaction     : 
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3.3.1  Mass Action Kinetics 
The law of mass action is derived by considering rate of collisions of the reactants in the 
reaction network [27]. Under the above assumptions, the law of mass action states that the rate of 
a chemical reaction is proportional to the abundance of the reactants. The abundance of 
molecules is defined as the concentration of the species. Generally, concentration is denoted as 
[.] [27]. 
By considering the networks in Figure 3.1, the reaction rates are given by the law of mass 
action as 
 
where   ,   ,   ,    and    are called the rate constants which are a concentration-independent 
measures of the velocity of a reaction [28]. The units of these rate constants are as follows: -the 
units of    is (concentration) (time)
-1
, the units of   is (time)
-1
, the units of        are 
(concentration)
-1
(time)
-1
, and    is (time)
-1
.
 
     
Generally, the rate constants are depicted as 
𝑘  A  𝑘  
A 
𝑘  
𝑘 [𝐴]  
A + B C 
𝑘  
𝑘 [𝐴][B]  
A + A 
𝑘  
D 
𝑘  
𝑘 [𝐴]
 , 𝑘 [𝐷] 
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                                                                     A                    B                                         (3.1) 
where k is a rate constant, A is reactant, and B is product. 
As an example of a mathematical model, consider the irreversible reaction in (3.1). Using 
mass action kinetics, we have the following. 
                                               
                                  ⁄⏟  
                  [ ]          
         ⏟
                       [ ]          
                (3.2) 
                                   ⁄⏟  
                  [ ]          
        ⏟
                      [ ]          
                (3.3) 
 
  where      and      denote the concentration of [A] and [B] at time t, respectively.   
3.4 Dynamic Behavior of Biochemical Reactions 
Individual chemical reactions as discussed above are referred to as elementary reactions. 
In contrast, some biochemical reactions, such as enzyme catalysis, are processes that involve 
small networks of individual elementary reactions. Unlike elementary reactions, mass action 
kinetics cannot be applied directly to biochemical reactions.   
We begin with a discussion of enzyme catalysis. In the following, enzyme kinetics will 
be described with particular assumptions. Michaelis-Menten kinetics, which describes the rate of 
enzyme-catalyzed reactions, will be derived as a result of these assumptions.  
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The general enzyme-catalyzed reaction was firstly proposed in 1902 by Adrian Brown [28] 
          
where [ ] [ ] [ ]  and [ ] denote the concentration of substrate, enzyme, complex, and product, 
respectively.   
When mass action kinetics is applied to the individual reactions in this network, a set of 
differential equations is obtained as follows: 
                  
 [ ]
  
       [ ][ ] +   [ ]                                                                    
                  
 [ ]
  
       [ ][ ] +    +    [ ]                                                      
                 
  [ ]
  
    [ ][ ]      +    [ ]                                                          
                         
 [ ]
  
    [ ]                                                                                                       
 
where the last equation gives the reaction rate (velocity) of the network, and generally it is 
denoted    Because the total enzyme concentration is conserved, the sum of [ ] + [ ] is constant 
and is denoted   . Thus, Equ (3.6) will be eliminated by taking into consideration [ ]  [  ]  
[ ]           
3.4.1.1 Quasi Steady State Approximation 
A separation of timescales can be applied to the network. The quasi-steady state 
assumption applies to species that reach equilibrium quickly compared to the rest of the network. 
[𝑆] + [𝐸]   [𝐶] [𝑃] + [𝐸] 
𝑘  
𝑘  
𝑘  
(3.4) 
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Following Briggs and Haldane [29], we assumed that the complex is in quasi-steady state. In 
quasi steady-state, the condition is [ ]  [    ], and      is an independent variable.  Thus;     
                                      [ ][ ]      +    [ 
   ]                                               
which is the quasi steady state assumption. Considering total enzyme concentration as a constant 
and this assumption together, we have                                                                  
                                                [    ]    
[  ][ ]
  +   
  
+ [ ]
                                                               
Finally, (3.10) substituting into (3.8), we obtain  
 
                                          
 [ ]
  
    
  [  ][ ]
  +   
  
+ [ ]
                                                          
writing        [  ] and    
     
  
  to rewrite (3.11), the reaction rate ( ) can be written 
as 
                                                  
    [ ]
  + [ ]
                                                             
 
This is called the Michaelis-Menten rate law.      is known as the maximal rate and    is 
referred to as the Michaelis constant, which is the substrate concentration at which the rate is 
half-maximal (see Figure 3.2). Also, this section could be review in Ref[30] and Ref[31].   
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Figure 3.2: Michaelis-Menten Kinetics for single-substrate enzyme catalyzed reaction. As the 
substrate concentration increases, the reaction rate approaches the maximal velocity. 
 
3.5 Cooperativity 
Some enzymes bind to more than one substrate molecule, and in some cases a bound 
substrate molecule affects the affinity of binding of others. This is referred to as cooperativity 
[32]. Cooperativity causes nonlinear behaviors.  
3.5.1 Hill function 
When an enzyme has   binding sites, the reaction rate can be described by a Hill 
function:   
𝑉𝑚𝑎𝑥 
𝑉𝑚𝑎𝑥
 
 
𝐾𝑀 
R
ea
ct
io
n
 R
a
te
 (
V
el
o
ci
ty
) 
Substrate Concentration  
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     [ ]
 
  
 + [ ] 
                                                                                
   and n are empirical parameters. 
Additionally,   is referred to as the Hill coefficient. This equation exactly reduces to 
Michaelis-Menten kinetics for        
Hill functions are commonly used to describe nonlinear and saturable behavior between 
species concentrations and their effects [32]. In this study, Hill functions are used to describe 
protein degradation. 
3.6 Gene Regulatory Networks 
Proteins are the essential ingredients for all cellular activities. Proteins are produced by 
gene expression, a process that occurs in two steps. Transcription, the first step, is copying of 
genetic information from one molecule (DNA) to the other (RNA). The resulting RNA molecule 
is called a messenger RNA (mRNA). The second step of gene expression is called translation. 
Through translation, the copied information is read along from the mRNA to synthesis a protein.    
Gene expression events involve a large number of elementary reactions, are not easily 
decomposable.  
Let us take a constitutive a gene expression model which is demonstrated in Figure 3.3. 
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Figure 3.3: Gene expression model 
 
                                             
     
  
                                                                     (3.14) 
                                             
     
  
                                                                   (3.15) 
 
where   is the concentration of mRNA molecules and   is the concentration of the gene’s 
protein product.    denotes the population-averaged transcription rate, and   is used to show the 
per-mRNA translation rate.    and    characterize the degradation rates of transcription and 
translation, respectively [27]. The degradation kinetics of the mRNA        and protein (    ) 
are assumed to follow the first order mass action kinetics with rates     and     respectively 
[27]. 
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3.6.1 Regulated Gene expression 
Let us take a regulated gene expression model which is demonstrated in Figure 3.4. 
 
Figure 3.4: A simple representative of a gene regulatory network 
 
A gene regulatory network consists of a group of genes’ products which are called as 
proteins, and they regulate other genes’ expression. If a gene protein product inhibits another 
gene’s expression, the gene product is called inhibitor; if the product enhances another gene 
expression, it is called activator [27]. In this study, when the rate of the reaction which is the 
activation of another gene expression by a gene protein product is given simply linear term. 
However, the inhibitory regulation reaction’s rate is described in the following: 
 
 
 +       
 
where  , the constant of the proportionality, is the maximal transcription rate. 
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or 
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3.7 Analysis of Dynamical Networks 
In this section, phase plane portrait analysis, sensitivity analysis, bifurcation analysis, and 
stability will be addressed. The main purpose of using these techniques is to examine the 
behavior of the nonlinear dynamical systems since usually there is no analytical solution for 
these systems to interpret their results.  
 
3.7.1 Stability Analysis 
A reaction network’s state is called stable when at long timescales the concentration of 
each of the chemicals in the reaction network remains constant. Alternatively, if the system 
settles into a pattern whereby the chemical levels oscillate predictably, it is called sustained 
oscillation. Stability analysis addresses, the long-time behavior of dynamical systems. This   
behavior could converge to either a stable state or a sustained oscillation [33]. Specifically, in 
this study, bistability will be considered.   
Bistability means having two different stable behaviors depending on the initial 
conditions. The most necessary components in the bistability system are positive feedback and 
nonlinearity. However, there is no guarantee that the system will exhibit bistability if it has these 
two components. As always, model structure and also model parameters should be taken into 
consideration for bistability [33].      
 
3.7.2 Phase Plane Portrait Analysis  
Phase plane portraits were introduced by Henri Poincare in the 19
th
 century [34]. These 
provide a graphical description of the behavior of nonlinear systems without requiring any 
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analytical solutions. By mapping trajectories starting at a range of initial conditions, the behavior 
of a system can be interpreted in terms of its stable and unstable steady states. Even though a 
phase plot does not emphasize the concentration change with respect to time, it points out the 
time-varying relationship between the variables [35]. Normally, this analysis can only be used 
for second-order systems.  
 
3.7.3 Bifurcation Analysis 
Bifurcation analysis describes changes in the position of steady states as the values of the 
model parameters are changed [27]. A parameter interval over which the system exhibits two 
stable steady states is known as a bistable range. The size of this interval indicates the robustness 
of the bistable behavior (to changes in parameter values). That is, if the size of this interval is 
small, then small perturbation will significantly affect the system behavior. On the other hand, if 
the interval’s size is large, system behavior will not be sensitive so much under the perturbations.  
 
3.7.4 Sensitivity Analysis 
An important method for the analysis of dynamical systems is sensitivity analysis. 
Sensitivity analysis describes how changes in the values of the parameters (which reflect the 
conditions of the system) affect the system behavior. Sensitivity analysis can be used to 
determine which parameters require additional research for strengthening the knowledge base, 
thereby reducing output uncertainty. Also, with the help of sensitivity analysis, insignificant 
parameters can be detected in order to eliminate them from the model. Moreover, sensitivity 
analysis can be used to identify which parameters have a significant impact on the output of a 
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model [36]. In this study, local sensitivity analysis will be used to address small variations 
around a nominal operating condition. 
3.7.4.1 Local Sensitivity Analysis  
In general, the dynamical system is described as: 
                                          
  
  
                                                                 
where   is dependent variables,   is the m-vector of system parameters (which can include the 
initial conditions   ), and   (time) is the independent variable [36]. In this thesis,   is considered 
to be a vector of parameter values. 
 
Bifurcation analysis represents one approach to investigating system steady state 
behavior under changes in the values of the model parameters. An alternative is local sensitivity 
analysis. Local sensitivity analysis allows an easily calculation of the effect on the steady state as 
the parameter values are varied from their nominal values. When we consider Equ.3.16, the 
absolute local sensitivity of a steady state    with respect to a variable   is given by the ratio of 
change of     with respect to k, i.e. 
    
  
  which is called the absolute sensitivity coefficient. 
Sensitivity coefficients are computed via finite difference methods by discretization of 
differential equations. Using this approach, we use (3.16) to define the sensitivity to the     
parameter    at the steady state of  
   as 
                                     
    
   
  
   (  +    )   
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with all other parameters held fixed [36].  This approach is using to predict the effect of small 
perturbations     at the parameter value       [27].  
 
To provide a measure of sensitivity that is independent of units and of the magnitudes of 
   and   , the absolute sensitivity coefficient can be scaled as follows: 
 
                                                                
   
  
 
    
   
                                                                                   
 
which is called the relative sensitivity coefficient; these provide a concise description of model 
behavior [27].  
 
The relative sensitivity coefficient describes how local changes in parameter values affect 
system behavior. If the sensitivity coefficient is small, then system behavior is robust with 
respect to perturbations to that parameter [27]. 
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Chapter 4 
Model 
4.1 Introduction  
In this chapter, first of all, a few previously published mathematical models will be 
discussed to highlight where the idea of building a new cell signaling network for the regulation 
of apoptosis comes from. Then, specific proteins in the network will be described, and the 
signaling pathway of interest will be presented. Next, a kinetic model of the reaction network 
will be developed. Finally, the analysis of the model will be presented.  
 
4.2 Bistability in the Apoptosis Pathway 
Apoptosis is a key process in cell regulation, and a number of mathematical models have 
been developed to address different aspects of the apoptotic mechanism. As we discussed in 
Chapter 2, apoptosis is regulated in a number of ways: extrinsic and intrinsic pathways are well-
known apoptotic regulatory pathways. Also, some proteins, such as p53 and Akt have important 
impacts on apoptotic pathways.  
4.2.1 Bistability in caspase3 activation 
Choi et al. [37] provided a mathematical model of caspase-3 activation describing 
regulation via three different pathways: activation via caspase8, inhibition via the protein XIAP, 
and activation via a complex of caspase3 and XIAP. The model was analyzed to assess the 
networks function in assuring the reliability and robustness of cell death. Moreover, Eissing et al. 
[38] developed a model of apoptosis exhibiting bistability. That model incorporated the extrinsic 
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apoptotic pathway: activation of caspase3, inhibition and degradation of caspase3 by XIAP, and 
activation of residual caspase8 by activated caspase3 in a feedback loop [10]. From these 
models, the current study draws its description of caspase3 activation, and XIAP inhibition of the 
caspase3.   
The model of Bagci et al. [39] focuses on the formation of the apoptosome (a pro-
apoptosis protein complex) and caspase3 activation. Bagci et al. [39] claimed that cooperativity 
provides robustness of bistability in comparison to the other regulatory mechanism. To prove the 
idea, Bagci et al. [39] developed a very large mathematical model with 32 ODEs. In our study, 
we did not examine specifically the regulation of the mitochondrial apoptotic pathway. Also, 
instead of using cooperativity for describing the formation of the apoptosome, we used 
cooperativity in the regulation of activated-caspase3 degradation via phosphorylated-XIAP.  
 
4.2.2  Bistability in Akt-p53 pathway 
Aguda and Wee studied the regulation of some proteins involve in the apoptotic signaling 
pathway [11]. The most important regulators of apoptosis are p53 and Akt, which mutually 
inhibit each other. Aguda and Wee assumed that the total Akt concentration was constant, and 
demonstrated bistability in a model that incorporates the proteins PTEN and Mdm2 into the p53-
Akt network [11]. 
In this study, we present a novel network model that builds on these previous efforts. In 
particular, the previous models have not addressed the combination of the three signaling 
networks including apoptosis, p53, and Akt. We aimed to build such a model and verify that it 
could exhibit bistable behavior.  We began the construction task by reviewing the signaling 
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pathways separately to understand their mechanisms on the regulation of cell metabolism. Then, 
we focused on the most important proteins on these networks: p53, Mdm2, PTEN, XIAP, 
caspase3, and Akt, which are heavily studied for cancer research. A detailed literature review 
was needed to build up a new signaling network model that describes the behavior of these 
proteins, and how they interact. These details will be given in the Model section.      
 
4.3  Model 
4.3.1 Experimental data for the pathways 
The numbers below correspond to the interaction labels in Figure 4.1. 
                 
 
Figure 4.1: Simplified biological network that includes and pro- and anti-apoptotic proteins. 
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In Figure 4.1, arrows show activation; while, hammerheads denote inhibition. 
 
 
p53 and Mdm2 (1, 2): Expression of the p53 protein is stimulated by cell damage, and p53 
activates cell death and cell cycle arrest in damaged cells. When cells are not stressed, i.e. in the 
normal cell environment, p53 is inhibited by Mdm2, which keeps p53 at a low concentration. 
Mdm2 achieves this inhibition by forming a complex with p53 in the nucleus [40].    
The Mdm2/p53 complex translocates from the nucleus into the cytoplasm, where Mdm2 
facilitates the degradation of p53 [41]. On the other hand, expression of the mdm2 gene is 
induced by p53 when cell stresses occur [42]. As a result, an autoregulatory feedback loop exists 
between p53 and Mdm2 [43]. 
In the model presented in this study, the formation of the p53-Mdm2 complex will not be 
included explicitly. Rather, a term is included that describes the Mdm2-dependent degradation of 
p53. 
 
PTEN and Aktp (3, 4): p53 and PTEN form a positive feedback loop. p53 induces expression of, 
PTEN [44]. Moreover, PTEN indirectly increases p53 protein level by protecting p53 from 
Mdm2-induced degradation, by negatively regulating the Akt/PKB growth signaling, which 
activates Mdm2 [45]. In the model, we will assume that PTEN directly inhibits Aktp (Figure 4.1). 
 
Mdm2 and Aktp (5): Phosphorylation of Mdm2 (Mdm2p) by activated phosphorylated Akt 
(Aktp) promotes the transport of Mdm2’s from the cytoplasm to the nucleus [23].  
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p53 and caspase3 (6): p53 can induce cell death by activating genes on both the extrinsic and 
intrinsic apoptotic pathways [46, 47]. Although the role of p53 in the extrinsic pathway is poorly 
understood, p53 activates death receptors (TNF-R family) and caspase 8 [20]. For this report, we 
will assume that p53 directly activates caspase3, which interacts with caspase8 and caspase9 and 
executes apoptosis (Figure 4.1).  
 
Aktp and caspase3 (7, 8): Phosphorylated Akt and activated caspase3 form a positive feedback 
loop. Apoptotic pathways are negatively regulated by Akt at the pre-mitochondrial level by 
phosphorylation and modulation of proteins [23]. Akt also promotes cell survival at the post-
mitochondrial level by directly phosphorylating and inactivating caspase9 [48]. Moreover, Akt 
inhibits caspase3’s activation by phosphorylating XIAP [23]. In contrast, active caspase3 inhibits 
Akt phosphorylation [26]. Consequently, in this report, we will assume that Aktp and caspase 3 
mutually inhibit one another (see Figure 4.1). 
 
XIAP and caspase3 (9, 10): Phosphorylated XIAP and activated caspase3 are involved in a 
mutual derepression positive feedback loop [49]. caspase3a decreases the XIAPp protein level, 
resulting in activation of caspase9 [50, 51]. In contrast, XIAPp is a direct inhibitor of caspase3 
activation [47, 48].  
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p53 and XIAP (11): p53 inhibits XIAP activity indirectly [52, 53]. In the model (Figure 4.1), we 
will suppose that p53 directly inhibits XIAP, although this interaction is known to involve other 
cellular components (e.g. the protein SMAC, and the mitochondria). 
 
Aktp, XIAPp, and PTEN (12, 13): Aktp phosphorylates XIAP both directly [54] and indirectly 
[55] to inhibit the activation of caspase3. On the other hand, XIAP overexpression induces Akt 
phosphorylation by enhancing degradation of PTEN [56]. 
   
This research was conducted by utilizing both quantitative and qualitative data collection 
tools. As described in the previous section, qualitative data was used to establish the model 
network.  
The second half of the study takes quantitative data into consideration to create a kinetic 
model. The kinetic model was developed by considering the regulation of each protein in the 
preceding figure in terms of production, degradation and regulatory reactions. With these 
additional details, we arrive at the network in Figure 4.2. The model was developed by 
assigning kinetic rates, taking into account enzyme and mass action kinetics introduced in 
Chapter 3. The ODEs are shown in Table1. For some kinetics, quasi steady state 
approximations and linearization of Michaelis-Menten kinetics were used. 
 
The numerical simulations of the ODEs were done using the MATLAB 7.10.0 (R2010a) 
computing environment. The values of most of the model parameters were collected from two 
different papers [10, 11]. Parameters for which the values were unavailable were chosen to 
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ensure bistability of the system. The initial concentrations are not significant, since our analysis 
focuses on long-time behavior.  
 
A schematic description of the above explanations is introduced in Figure 4.2. The model 
includes 7 species and 27 reactions. The total number of parameters in the model is 38, 
comprised of 6 production rates, 11 degradation rates, 2 Hill coefficients, 2 Michaelis-Menten 
constants, and 17 rate constants. The set of differential equations, their kinetic rates, and the 
kinetic rate constants are shown in Table 1, Table 2, and Table 3. 
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Figure 4.2: Kinetic scheme of the model 
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This kinetic scheme has four feedback loops (p53-Mdm2, p53-Akt, p53-apoptosis, and 
Akt-apoptosis) and three phosphorylation-dephosphorylation cycles that are Akt-Aktp, XIAP-
XIAPp and Mdm2-Mdm2p; Aktp, XIAPp, and Mdm2p illustrate biochemically active Akt, XIAP, 
and Mdm2 proteins upon phosphorylation. The kinetic rates on the arrows will be given in the 
appendix as Table 2. Blue arrows denote the production rate, while red arrows show the 
degradation rate. Regulatory networks are shown with the green arrows. Cycles are used to 
describe the phosphorylation, dephosphorylation or activation depending on the proteins and 
their direction. Each parameter’ units are given in Table 3 (in the last column, we have used  A, 
B, and C to explain the estimation of parameters; see Table 5). 
Table 1: Model equations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Differential Equations 
 [   ]   ⁄                                       
 [    ]   ⁄                                      
 [    ]        ⁄                                 +    
 [     ]   ⁄                                    
 [   ]   ⁄                                                +     
 [    ]   ⁄                                     +         
 [     ]   ⁄                                           
 [      ]   ⁄                              +             
 [    ]   ⁄                                            
 [     ]   ⁄                                     +         
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Table 2: Kinetic rates 
 
 
Kinetic Rate References  
                Mass action 
             [     ] +           [   ] Mass action 
                  +    [   ]  Mass action  
                  +    [     ]  [    ] Mass action 
                 +     [   ] Mass action 
                 [    ] Ref 11 
           [    ]  [    ]            Modify via 
linearization 
           [     ] Modify via 
linearization 
                  [      ] Ref 11 
               Mass action 
               [   ] Mass action 
             [(     [    ] +    (        [    ]
  
       [    ] +         )
 
   )       [    ]    ]  
[   ]    + [   ]          
Modify from 
Ref 11 via 
QSSA 
explained in 
Appendix. 
           [    ]    + [    ]  Ref 11 
            [      ] +             [    ] Mass action 
                  Mass action 
                 [     ]  Mass action 
            [     ]  [   ]       + [    ]⁄   Mass action 
            [     ]
  +              [      ] Mass action 
                Mass action 
                [    ] Mass action 
           [    ]  [    ]         + [   ]  Mass action 
                 +     [      ]
    [     ] Ref 10 
           [     ]  [      ] Ref 10 
           [       ] Mass action 
                   [       ] Mass action 
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Table 3: Kinetic rate constants 
 
Parameter
s 
Description Units 
Value 
used 
Bistable 
Ranges 
References Notes 
1 ksynp53 production of p53 µM/min 0.02 
80%-140% 
(0.016-0.028) 
60  
2 kdegp53 degradation of p53 /min 0.02 
20%-110% 
(0.004-0.022) 
60  
3 k1 
degradation of p53 via 
      
/(min*µM) 0.25 
63.2%-
105.28% 
(0.158-0.2632) 
60 A 
4 ksynPTEN production of PTEN µM/min 0.0018 - 60 B 
5 
k2 
 
Increased production  
of PTEN via p53 
/min 0.0012 - 11 A 
6 kdegPTEN degradation of PTEN /min 0.0054 - 60  
7 k3 
degradation of PTEN 
via XIAPp 
/(µM*min) 0.03 - arbitrary  
8 ksynMdm2 production of Mdm2 µM/min 0.0018 
12%-120% 
(0.0002-
0.00216) 
60 B 
9 k4 
Increased production 
of Mdm2 via p53 
/min 0.01 
40%-120% 
(0.004-0.012) 
11 A 
10 k5 
Phosphorylation of 
Mdm2 via Aktp 
/(µM*min) 10 
40%-120% 
(4-12) 
11 A 
11 k6 
dephosphorylation of 
Mdm2p 
/min 0.8 
80%-180% 
(0.64-1.44) 
11 
 
A 
12 kdegMdm2 degradation of Mdm2 /min 0.005 
80%-180% 
(0.004-0.009) 
60 
 
13 
kdegMdm2
p 
degradation of Mdm2p /min 0.005 
80% 
(0.004-) 
60 
 
14 
ksynAkt 
 
production of Akt µM/min 0.09 
40%-120% 
(0.036-0.108) 
arbitrary 
 
15 kdegAkt Degradation of Akt /min 0.08 
80% 
(0.064-) 
arbitrary 
 
16 k8 
Inhibition of 
phosphorylated-Akt 
via PTEN 
µM/min 0.06 
80%-120% 
(0.048-0.072) 
arbitrary 
 
17 j8 
Michaelis-Menten 
kinetics 
µM 0.1 
80% 
(0.08-) 
-  
18 k9 
dephosphorylation of 
Aktp 
µM/min 0.2 
80%-120% 
(0.16-0.24) 
11  
19 j9 
Michaelis-Menten 
constant of 
dephosphorylation of 
Aktp 
µM 0.1 
80%-120% 
(0.08-0.12) 
11  
20 k10 
Increased degradation 
of Aktp via casp3a 
/(µM*min) 0.01 
80% 
(0.008-) 
arbitrary  
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21 kdegAktp degradation of Aktp /min 0.01 
80% 
(0.008-) 
arbitrary  
22 ksyncasp3 
Production of 
caspase3 
µM/min 0.012 
80%-140% 
(0.0096-
0.0168) 
10 C 
23 kdegcasp3 
Degradation of 
caspase3 
/min 0.06 
40%-120% 
(0.024-0.072) 
10 C 
24 k11 
Increased activation of 
caspase3 via p53 
/min 0.03 
80%-200% 
(0.024-0.06) 
arbitrary 
 
25 k12 
Inhibition of caspase3 
activation via Aktp 
/min 0.05 
80% 
(0.06) 
arbitrary 
 
26 k13 
Increased degradation 
of caspase3a via 
XIAPp 
/(µM*min) 0.01 
60%-120% 
(0.006-0.012) 
arbitrary C 
27 kdegcasp3a 
degradation of 
caspase3a 
/min 0.001 
120% 
(0.0012) 
10 C 
28 ksynXIAP production of XIAP µM/min 0.0024 - 10  
29 kdegXIAP degradation of XIAP /min 0.06 
80%-140% 
(0.048-0.084) 
10 C 
30 k14 
Phosphorylation of 
XIAP via Aktp 
/min 0.3 
60%-120% 
(0.18-0.36) 
arbitrary  
31 k15 
Inhibition of 
phosphorylated-XIAP 
via p53 
µM 0.1 
80%-200% 
(0.08-0.2) 
arbitrary  
32 k16 
Increased degradation 
of XIAP via caspase3a 
/(µM*min) 0.01 
80%-160% 
(0.008-0.016) 
arbitrary C 
33 kdegXIAPp degradation of XIAPp /min 0.0024 
80%-160% 
(0.00192-
0.00384) 
arbitrary  
34 k17 
caspase3a inhibits 
XIAPp through 
caspase3-XIAP 
complex(C3*X) 
/(µM*min) 0.01 
120% 
(0.012) 
10 C 
35 
kdegcompl
ex 
degradation of 
complex 
/min 0.06 
120% 
(0.072) 
10 C 
36 k18 
activation of caspase3 
by releasing caspase3 
from the C3*X 
/min 0.06 
80% 
(0.048) 
10 C 
37 n1 
Hill coefficient of 
XIAPp dependent 
degradation of 
caspase3a 
- 2 
90%-270% 
(1.8-5.4) 
arbitrary  
38 n2 
Hill coefficient of 
caspase3a degradation 
of XIAPp 
- 1 
60% 
(0.6) 
arbitrary  
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4.4 Results and Discussion 
In this section, the results of the model will be presented using the analysis techniques 
introduced in Chapter 3.  
    
                                 
Figure 4.3: Bistability between casp3a and XIAPp 
Figure 4.3 shows that the systems long-time behavior depends on the initial conditions: 
the model is bistable. We refer to the steady state with high levels of active caspase3 (casp3a) as 
the “death state”; low caspase3a corresponds to the “life state”.  
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Table 4: Two stable points depending on the initial concentrations (µM) of the variables 
 Cell death stable points Cell survival stable points 
p53 0.2235 0.2216 
PTEN 0.2964 0.0497 
Mdm2 0.5292 0.5220 
Mdm2p 0.2779 0.2811 
Akt 1.1103 1.1192 
Aktp 0.0423 0.0433 
caspase3 0.0904 0.0915 
caspase3a 1.7904 0.0693 
XIAP 0.2419 0.2390 
XIAPp 0.3242 2.8092 
caspase3-XIAP complex 
(C3*X) 
0.0484 0.0162 
 
Table 4 shows concentrations of the model species at the two stable steady states. The 
cell death state is reached by choosing pro-apoptotic proteins (p53, PTEN, caspase3, caspase3a) 
at a high initial concentration compared with the anti-apoptotic proteins (Mdm2, Mdm2p, Akt, 
Aktp, XIAP, XIAPp, C3*X). On the other hand, the life state is obtained from an initial condition 
in which the cell survival proteins have high concentrations. From the stability analysis, we can 
see that PTEN, caspase3a, and XIAPp are the most distinctive stable steady states depending on 
the initial concentrations. The rest of the proteins are almost the same stable steady states even 
though the initial concentrations are different. 
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Activated caspase3 is characterized the effector of cell death: phosphorylated XIAP is 
known as the main inhibitor of activated caspase3. Thus, having two very different steady state 
values for these two proteins as shown in Table 4 is expected.  The most interesting finding from 
the steady state concentrations is protein PTEN, which likewise exhibits two distinctive steady 
states. PTEN functions as an intermediary protein through a number of interactions in the 
signaling pathway. For instance, the formation of many cancers is associated with mutations in 
PTEN including breast, prostate, and brain cancers. Themsche et al. [56] pointed out that 
increased synthesis of XIAPp causes the increased PTEN degradation.  Numerically, we showed 
that while PTEN is high, XIAPp is low; on the other hand, if XIAPp steady state value is high 
which means XIAP synthesis level is high, the steady state of PTEN is decreasing, as in Table 4. 
We also showed this result by using bifurcation analysis of ksynXIAP (production of XIAP) with 
respect to PTEN steady state value; however, the result will not be shown in the text.  
 An alternative demonstration of bistability is provided by a phase plane portrait. Figure 
4.4 shows projections of the model’s 11-dimensional trajectories onto the caspase3a- and XIAPp-
plane.  
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Figure 4.4: Projected phase plane portrait. 
   
Next, we employed bifurcation analysis to explore the robustness of bistability. For each 
model parameter, we considered the range of parameter values over which bistability is 
maintained (while the other model parameters were fixed at their nominal values as given in 
Table 3).  
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Figure 4.5: Bifurcation diagram for the bistable system. 
 
 
Figure 4.6: Continuation diagram for the bistable system 
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Figure 4.5 and Figure 4.6 illustrate this analysis. These both show the steady state 
concentration of active caspase3 as a function of parameter values. In Figure 4.5, we see that at 
low and high k1 values- the system is monostable. However, in the mid-range of k1 (degradation 
of p53 via Mdm2p), two stable steady states appear. The size of this interval indicates the 
robustness of bistability with respect to this parameter.  That is, when the size of this interval is 
small, system behavior will be fragile to any perturbation. However, if the size is large, system 
behavior will not be affected significantly by perturbations. On the other hand, in Figure 4.6, 
caspase3a has two stable steady state values for every value of parameter k2 (increased 
production of PTEN via p53). That is, the system is bistable for any value of k2 (with the other 
values in Table 3) is infinite. The range of the each parameter in the model is added in Table 3. 
These ranges indicate how robust the system’s bistability is to changes in the values of the 
individual parameters. For example, parameter k3, which characterizes the rate of degradation of 
PTEN by XIAPp, has an infinite bistable range, indicating that bistability will not be lost 
regardless of the value of this parameter (for the other parameters at their nominal values). 
Conversely, the parameter kdegMdm2, which characterizes the rate of degradation of Mdm2, has 
a narrow bistability range of only 0.004-0.009 /min, with a nominal value of 0.005 /min. Thus a 
change of as little as 20% in the value of this parameter can cause the system to become 
monostable, so that only one cell fate can be reached.  
  
Finally, sensitivity analysis was employed to explore the parameters’ effect on the model. 
We applied a local sensitivity analysis (as described in Chapter 3) at both the life and death states 
(Figure 4.7-4.17).  
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Figure 4.7: Sensitivity analysis at life state for pro-apoptotic proteins_1 
 
ksynp53 (production of p53) has a positive impact on p53; while, k1 (degradation of p53 
via Mdm2p) has a negative impact. On the other hand, these two proteins cannot cause the 
change of bistable range of the protein p53 in the bifurcation analysis. ksynPTEN (production 
of PTEN) affects PTEN positively; ksynMdm2 (production of Mdm2) negatively affects the 
protein PTEN.  However, from the bifurcation analysis, this effect cannot significantly cause the 
change of the range of the bistability. 
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Figure 4.8: Sensitivity analysis at life state for pro-apoptotic proteins_2 
 
kdegcasp3 (degradation of caspase3) affects protein caspase3. The bistable range of this 
protein via obtained kdegcasp3 has changed very little. The protein caspase3a has negatively 
affected by k13 (increased degradation of caspase3a via XIAPp), kdegcomplex (degradation of 
C3*X), while, k18 (the activation of caspase3 by releasing caspase3 from C3*X) has a positive 
impact on activated caspase3. From the bifurcation anaylsis, only k13 has caused a big change of 
the range of bistability of caspase3a.  
Also, the hill coefficient n1(Hill coefficient of XIAPp dependent degradation of 
caspase3a) affects the range of protein caspase3a significantly. This means this high sensitivity 
corresponds to the change of the bistable range of caspase3a depending on n1.  
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Figure 4.9: Sensitivity analysis at the death state for pro-apoptotic proteins_3 
 
This graphs shows that k1(degradation of p53 via Mdm2p), k5 (phosphorylation of 
Mdm2 via Aktp), k8 (inhibiton of phosphorylated Akt via PTEN), and j9 (Michaelis-Menten 
constant of dephosphorylation of Aktp) have negative impact on p53; while, k6 
(dephosphorylation of Mdm2p) and k9 (dephosphorylation of Aktp) affect positively the protein 
p53.  Also, k1, k4 (increased prodcution of Mdm2 via p53), k5, k8, and j9 have a positive effect 
on caspase3; while, k9 has impact on caspase3 negatively.  
Moreover, k3 (degradation of PTEN via XIAPp) seems effect PTEN value significantly. 
This result also match with the bifurcation analysis since k3 affects the range of PTEN 
bistability infinitely.  
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Figure 4.10: Sensitivity analysis at the death state for pro-apoptotic proteins_4 
 
k10 (increased degradation Aktp via caspase3a), kdegcasp3, and k11 (increased activation 
of caspase3 via p53) have a significant negative impact on caspase3; whereas, k12 (inhibition of 
caspase3 activation via Aktp) affects caspase3 positively. However, this high sensitivity of k12 
on caspase3 is not a significant impact on the range of the bistable of caspase3.  
In addition, k10 affects p53 positively. Also, while n2 (Hill coefficient of caspase3a 
degradation of XIAPp) have most influential effect on the proteins PTEN and caspase3a 
positively, k18 (activation of caspase3 by releasing caspase3 from the C3*X) affects PTEN 
protein negatively. 
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Figure 4.11: Sensitivity analysis at the life state for anti-apoptotic proteins_1 
 
While k5 (phosphorylation of Mdm2 via Aktp) has a negative effect on the protein 
Mdm2, k6 (dephosphorylation of Mdm2p) affects positively. The high sensitivities of these two 
parameters on Mdm2 cannot cause the big change of the Mdm2 bistable range.  
Another important parameter in this graph is kdegAkt (degradation of Akt). kdegAkt 
affects Akt negatively. However, this effect does not influence on the bistable range of Akt.  
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Figure 4.12: Sensitivity analysis at the life state for anti-apoptotic proteins_2 
 
kdegAktp (degaradation of Aktp), ksynXIAP (production of XIAP), and k15 (inhibition of 
phosphorylated XIAP via p53) have a positive impact on the protein XIAP; while, k14 
(phosphorylation of XIAP via Aktp) has a negative impact on it. Also, the parameter kdegAktp 
(degradation of phosphorylated Akt) affects the protein Mdm2 and Aktp positively. Moreover,  
the protein C3*X (caspase3-XIAP complex) is negatively affected by kdegcomplex (C3*X 
degradation), k18 (activation of caspase3 by releasing caspase3 from the C3*X) and n1 (Hill 
coefficient of XIAPp dependent degradation of caspase3a); whereas, k17 (caspase3a inhibits 
XIAPp through caspase3-XIAP complex (C3*X)) affects the complex positively.   
 
 
-1
-0.5
0
0.5
1
k1
0
kd
eg
A
kt
p
ks
yn
ca
sp
3
kd
eg
ca
sp
3
k1
1
k1
2
k1
3
kd
eg
ca
sp
3
a
ks
yn
X
IA
P
kd
eg
X
IA
P
k1
4
k1
5
k1
6
kd
eg
X
IA
P
p
k1
7
kd
eg
co
m
p
le
x
k1
8
n
1
n
2
Sensitivity analysis for anti-apoptotic proteins and the second half 
of the parameters with cell survival initial values 
Mdm2 Mdm2p Akt Aktp XIAP XIAPp complex
  49 
         
Figure 4.13: Sensitivity analysis at the death state for anti-apoptotic proteins_3 
 
Most influential parameters on Mdm2p are k5 (Phosphorylation of Mdm2 via Aktp), k6 
(dephosphorylation of Mdm2p), k8 (Inhibition of phosphorylated-Akt via PTEN), k9 
(dephosphorylation of Aktp), and j9 (Michaelis-Menten constant of dephosphorylation of Aktp). 
Also, XIAPp is significantly affected the changes of k1 (degradation of p53 via     ), k8, and 
k9. 
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Figure 4.14: Sensitivity analysis at the death state for anti-apoptotic proteins_4 
 
The most important outcome from this analysis is that k10 (increased degradation of Aktp 
via caspase3a), kdegcasp3a (degradation of activated caspase3), k11 (increased activation of 
caspase3 via p53), k13 (increased degradation of caspase3a via XIAPp), k16 (increased 
degradation of XIAP via caspase3a), k17 (caspase3a inhibits XIAPp through caspase3-XIAP 
complex (C3*X)), kdegcomplex (degradation of C3*X), k18 (activation of caspase3 by releasing 
caspase3 from the C3*X), n1 (Hill coefficient of XIAPp dependent degradation of caspase3a), 
and n2 (Hill coefficient of caspase3a dependent degradation of XIAPp) have an important effect 
on XIAPp.   
 
Overall from the each of the sensitivity analysis in the above, it was found that the values 
of the parameters kdegPTEN (degradation of PTEN), kdegp53 (degradation of p53), k2 
(increased production of PTEN via p53), k3 (degradation of PTEN via XIAPp) have little impact 
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on system behavior. Conversely, the most influential parameter on the model is k1(degradation 
of p53 via Mdm2p). This has a negative impact on p53, and a positive effect on phosphorylated 
XIAP which triggers a cell to avoid apoptosis.  The results of the sensitivity analysis are attached 
in the Appendix. 
From the sensitivity analysis, it is shown that k13, which characterizes increased 
degradation of caspase3a via XIAPp, has a significant impact on the protein concentration, and 
thus on the system behavior.  
From the sensitivity analysis, k1 (the rate of degradation of p53 via Mdm2P) is found to 
be another influential parameter. Biologically, this parameter is important in determining cell 
fate. Depending on the parameter value, the cell fate will change as follows: If the parameter 
value is high, cell goes to the cell survival; otherwise, cell undergoes the cell death since p53 
protein has a positively significant effect on activated caspase3 [65].  
Moreover, another important parameter from the sensitivity analysis is the Hill 
coefficient n1 (Hill coefficient of XIAPp dependent degradation of caspase3a). Basically, our 
model is built on the cooperativity of XIAPp and caspase3a. Thus, the change of the n1 value 
affects the system behavior very significantly since n1 represents the nonlinearity of the system 
and provides positive feedback loop with another parameter n2 (Hill coefficient of caspase3a 
dependent degradation of XIAPp) between activated casapse3 and phosphorylated XIAP.  
From the biological perspective, ksyncasp3 (production of caspase3) and kdegcasp3a 
(degradation of caspase3a) parameters should have an influential effect on the system behavior 
since their values affect the activated caspase3 concentration, and implicitly the cell fate. 
Numerically, from the sensitivity analysis, their effects were found really to be very low. 
  52 
Nevertheless, from the bifurcation analysis, their impacts on the system behavior were obtained 
differently. It is shown that the bistable range of ksyncasp3 is small; it influentially affects the 
system behavior with the any small perturbation. On the other hand, kdegcasp3a has wide 
bistability range since there is no lower bound for the bistable range. 
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Chapter 5 
Conclusion and Future Directions 
5.1 Conclusion 
The development of cancer begins with the misregulation of normal cells at the molecular 
level. By considering this bio-molecular starting point of cancer, we investigated an important 
cell signaling network. In previous studies, Legewie et al. [10] discovered bistability in the 
intrinsic apoptotic pathway. On the other hand, Wee and Aguda [11] proposed bistability by 
considering the p53-Akt networks. Also, Bagci et al. [39] claimed that the most important 
feature for bistability of the system is to have a cooperative effect among the species. By taking 
into consideration these important findings, we developed a kinetic model consisting of three 
important cell signaling networks: apoptotic, p53 and Akt pathways. The purpose of building this 
kinetic model was to show bistability of the system since bistability is crucial for cell fate in 
terms of either cell death or survival.   
To achieve this goal, first of all, we reviewed the literature to understand the mechanism 
of proteins in these pathways. Then, based on the biological data, we built up a kinetic model to 
analyze the behavior of the system. From stability and phase plane portrait analysis, we 
demonstrated that our kinetic network is bistable by considering pro- and anti-apoptotic proteins. 
From bifurcation and sensitivity analyses, we found that k1 (increased p53 degradation via 
Mdm2p) is a key parameter for the control of the system; while, k2 (increased production of p53 
via PTEN), k3 (degradation of PTEN via XIAPp), kdegPTEN (constitutive degradation of PTEN) 
have little impact on system behavior. 
  54 
 The most challenging part of the research is to find appropriate values of the parameters.  
The weakness of this study is that we didn’t compare our result with the previously published results 
because of not having enough time. And also, 15 parameters were chosen arbitrarily, but some of 
them were obtained by applying quasi steady state approximation to existence value in the previous 
study. The rest of them were chosen by considering maintaining the bistability. Even though these 
parameters do not show significant effect on the model from the sensitivity analysis, they make it 
difficult to have confidence in the model predictions. More numerical calculations are required to 
validate our results. 
5.2 Future Works 
Based on the present study, two other projects are being considered for the future. The first 
project is to extend the presented kinetic model by adding other proteins studied by Legewie et al. 
[10]. The pathways for his project are illustrated in Figure 5.1. 
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Figure 5.1: Proposed model to study apoptotic-p53-Akt pathways 
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Akt-p53-apoptotic pathways combine with specific proteins. In the Figure, apoptotic 
pathways are shown with the extrinsic and intrinsic pathways. The pink bubble shows the 
regulation of p53 via Mdm2, and also their negative feedback loop starting from the cytoplasm 
ending in the nucleus. The blue bubble illustrates the mitochondria. Cell stresses, growth factor, 
and death receptors are the external stimuli for these three important pathways. p53’s effect on 
the apoptotic pathway is demonstrated with three different pathways including PTEN activation 
to inhibit Akt function, inducing TNF-R family in the extrinsic pathway, and initiating the 
activation of Bax in the mitochondria for the intrinsic pathway. On the other hand, the inhibition 
of the apoptotic pathway via Akt is demonstrated in three different ways. The inhibition of 
protein Bax via Akt causes the block of apoptosis. Also, Akt inhibits apoptosis via the activation 
of XIAP. In addition, Akt prevents the formation of the apoptosome consisting of APAF1 and 
caspase9 protein. It results in the inhibition of caspase3 activation. 
 
The second project is to introduce a cancer drug to the present study. Cisplatin, a well-
known and crucial chemotherapeutic drug, is widely used as a cancer treatment tool in breast, 
testicular, head and neck, bladder, lung, ovarian, cervical, prostate, and refractory non-Hodgkin’s 
lymphomas. The usage of cisplatin in cancer treatment is generally associated with DNA 
damage, resulting in apoptosis, even though cisplatin can interact with the other cellular 
components. Thus, by considering cisplatin-induced DNA damage, our first objective would be 
to incorporate cisplatin into the mathematical model (Figure 5.2) [57]. When we are dealing with 
the cisplatin effect on the present model, we will consider the mechanism of cisplatin resistance, 
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which can cause secondary cancer formation [58] by switching the desirable effect of cisplatin 
during the treatment of malignancy [59]. 
 
  
Figure 5.2: Cisplatin Resistance Pathways 
 
In summary, the present study represents a step toward understanding the mechanisms of 
cancer signaling pathways. This knowledge will be useful in developing treatment for this 
condition, which is one of the most significant problems with human health worldwide. The 
proposed future work will extend this initial analysis to a more complete description of 
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intracellular behavior, and will address the ability of the drug Cisplatin to interfere with these 
pathways and thus improve health outcomes.  
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Appendix  
 
Table 5: Modified Kinetics 
 Explanation  
A Linearized Michaelis-Menten kinetics. 
B QSSA was applied to pten gene in Ref 60. 
C The same value used in Ref 10, but we only changed the units. 
 
Table 6: Sensitivity analysis results for Cell Survival Initial values 
 
p53 PTEN Mdm2 Mdm2p Akt Aktp casp3 casp3a XIAP XIAPp C3*X 
ksynp53 0.999964 0.015248 4.71E-05 2.04E-05 2.64E-05 -2.48E-05 -0.00013 0.000571 0.040364 -2.02E-05 3.03E-05 
k1 -0.90468 0.018167 -0.00056 -0.000105 -8.09E-05 0.000453 0.000593 -0.00718 -0.03691 0.002005 -0.0026284 
kdegp53 -0.00421 -0.00015 -2.40E-06 -4.78E-07 -3.78E-07 1.94E-06 2.68E-06 -3.11E-05 -0.00017 8.80E-06 -1.18E-05 
ksynPTEN 5.32E-06 0.528039 0.00067 -6.91E-06 0.000835 -0.00069 -9.66E-09 -3.91E-07 0.000652 -3.67E-08 -1.14E-08 
k2 1.89E-07 0.01597 2.33E-05 -2.40E-07 2.89E-05 -2.39E-05 -3.60E-10 -6.33E-09 2.27E-05 -1.29E-09 -2.72E-10 
kdegPTEN -3.81E-08 -0.0295 -6.43E-05 6.63E-07 -7.75E-05 6.57E-05 1.74E-09 1.42E-06 -6.35E-05 3.41E-09 2.30E-08 
k3 -0.00024 -2.5148 -0.00984 0.0001014 -0.01191 0.010044 3.40E-07 4.07E-07 -0.00964 4.93E-07 7.08E-06 
ksynMdm2 -0.0009 -1.13E-05 0.001039 0.0009207 -1.78E-08 1.76E-08 7.01E-08 -5.13E-07 -3.60E-05 2.17E-08 -2.81E-08 
k4 -0.00012 -2.50E-06 0.000126 0.0001235 -5.14E-09 1.62E-08 4.04E-08 -3.01E-07 -4.95E-06 7.40E-08 -9.28E-08 
k5 -0.00923 0.00196 -0.90039 0.0092815 3.68E-06 1.52E-05 1.54E-05 -0.00041 -0.00033 8.25E-05 -0.0001243 
k6 0.010004 0.005387 0.988652 -0.010194 -2.38E-05 1.65E-05 -5.01E-06 2.14E-06 0.000451 -1.82E-05 2.91E-05 
kdegMdm2 0.000461 6.24E-06 -0.00054 -0.000474 1.04E-08 -1.82E-08 -4.78E-08 4.11E-07 1.85E-05 -5.58E-08 7.36E-08 
kdegMdm2p 0.04832 0.000617 -0.04931 -0.049379 9.75E-07 -9.83E-07 -3.83E-06 2.79E-05 0.001942 -1.26E-06 1.66E-06 
ksynAkt -5.55E-07 -7.64E-09 -5.76E-05 5.94E-07 0.102914 5.84E-05 2.42E-09 -3.51E-08 -5.75E-05 3.62E-09 -2.58E-10 
kdegAkt 4.16E-06 7.06E-08 0.00043 -4.44E-06 -0.65989 -0.00044 -1.88E-08 2.63E-07 0.00043 -2.72E-08 2.07E-09 
k8 -0.00079 -4.49E-05 -0.07947 0.0008195 -0.07592 0.081095 5.95E-06 -6.36E-05 -0.07971 9.22E-06 -5.48E-06 
j8 1.03E-05 4.87E-07 0.001048 -1.08E-05 0.001022 -0.00106 -7.07E-08 7.90E-07 0.00105 -1.08E-07 5.55E-08 
k9 0.002435 0.000138 0.244931 -0.002526 0.225698 -0.242 -1.83E-05 0.000196 0.245722 -2.82E-05 1.66E-05 
j9 -2.67E-05 -1.40E-06 -0.00269 2.77E-05 -0.00258 0.002724 1.93E-07 -2.10E-06 -0.0027 2.96E-07 -1.66E-07 
k10 5.21E-05 4.48E-05 0.005145 -5.30E-05 -1.16E-05 -0.0052 -1.35E-06 1.97E-05 0.005177 -5.31E-06 6.53E-06 
kdegAktp 0.00107 6.66E-05 0.107308 -0.001107 -0.00016 -0.10745 -8.46E-06 8.86E-05 0.107701 -1.32E-05 8.30E-06 
ksyncasp3 1.27E-10 6.09E-08 2.21E-08 -1.31E-10 1.05E-10 -2.23E-08 0.141289 7.11E-05 2.20E-08 -3.69E-08 7.87E-07 
kdegcasp3 -1.02E-09 -2.73E-07 -9.60E-08 1.09E-09 -4.64E-10 9.72E-08 -0.53753 -0.00027 -9.62E-08 1.59E-07 -3.31E-06 
k11 2.75E-08 9.49E-06 2.41E-06 -2.47E-08 1.93E-08 -2.43E-06 -0.00066 0.000559 2.42E-06 -3.13E-06 4.13E-05 
k12 -2.10E-10 -4.80E-08 -1.22E-08 2.22E-10 -9.73E-11 1.23E-08 3.39E-06 -3.50E-06 -1.23E-08 1.59E-08 -2.14E-07 
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Table 7: Sensitivity analysis for Cell Death Initial values 
 
p53 PTEN Mdm2 Mdm2p Akt Aktp casp3 casp3a XIAP XIAPp C3*X 
ksynp53 0.210548 0.001603 0.002278 0.000973 -0.00015 -0.00095 -0.08733 0.007529 0.013014 -0.00871 6.56E-05 
k1 -2.36577 -0.09335 -0.10866 -0.044318 0.013264 0.051123 2.838232 -0.29512 -0.46969 0.363695 -0.0023087 
kdegp53 -0.16447 -0.00436 -0.00531 -0.002555 0.00061 0.002081 0.137896 -0.01405 -0.02194 0.016973 -0.0001295 
ksynPTEN 2.98E-08 0.002235 3.14E-08 -6.17E-08 4.15E-09 -1.11E-07 -3.44E-08 3.03E-09 9.93E-09 -5.01E-09 -9.54E-11 
k2 6.39E-07 0.028861 4.93E-07 -9.64E-07 6.77E-08 -1.56E-06 -7.96E-07 7.37E-08 2.13E-07 -1.12E-07 -1.99E-09 
kdegPTEN -7.81E-07 -0.05339 -7.83E-07 1.54E-06 -1.03E-07 2.71E-06 9.11E-07 -8.08E-08 -2.60E-07 1.32E-07 2.48E-09 
k3 -6.25E-06 -0.40004 -6.22E-06 1.22E-05 -8.15E-07 2.13E-05 7.24E-06 -6.40E-07 -2.07E-06 1.04E-06 1.99E-08 
ksynMdm2 -0.00919 -0.00014 0.00842 0.0074167 1.41E-05 7.09E-05 0.006044 -0.00056 -0.00093 0.000657 -4.91E-06 
k4 -0.16473 -0.00432 0.093288 0.0991679 0.000408 0.005737 0.143134 -0.01423 -0.02279 0.016541 -1.08E-05 
k5 -0.65196 -0.01273 -0.32894 0.6118493 0.001665 0.008567 0.45498 -0.04429 -0.07107 0.052308 -0.0002744 
k6 0.921951 0.012791 0.350715 -0.652807 -0.00143 -0.00642 -0.55176 0.050945 0.083233 -0.06017 0.00059585 
kdegMdm2 0.01075 0.000114 -0.01853 -0.014436 -1.12E-05 -6.62E-05 -0.00552 0.000492 0.000837 -0.00058 4.27E-06 
kdegMdm2p 0.048544 0.00077 -0.02884 -0.0337 -7.99E-05 -0.00041 -0.03295 0.003052 0.005072 -0.0036 2.69E-05 
ksynAkt -0.01342 -0.0003 -0.01107 0.0216872 0.448696 0.036551 0.016681 -0.00154 -0.00452 0.00238 4.20E-05 
kdegAkt 0.015946 0.00033 0.013955 -0.027359 -0.52741 -0.04658 -0.01941 0.001774 0.005327 -0.00278 -4.99E-05 
k8 -0.75059 -0.02621 -0.47472 0.9217082 -0.07677 1.448465 1.136326 -0.11339 -0.29884 0.166064 0.00294553 
j8 0.057625 0.001929 0.031404 -0.060784 0.005075 -0.09179 -0.08196 0.008262 0.02027 -0.01173 -0.0001652 
k9 1.70487 0.062882 0.483227 -0.908216 0.102337 -1.16485 -2.34651 0.248646 0.517223 -0.32906 -0.0028938 
j9 -0.45262 -0.01309 -0.31094 0.6058618 -0.04571 0.920347 0.638034 -0.06133 -0.17081 0.090981 0.00184372 
k10 0.535923 0.02628 0.095796 -0.171623 -0.11716 -0.18547 -0.87156 0.096389 0.19127 -0.12665 -0.0010109 
kdegAktp 0.037323 0.002084 0.00695 -0.012403 -0.00886 -0.01293 -0.06648 0.007443 0.014848 -0.00981 -9.26E-05 
ksyncasp3 0.000287 0.000265 0.000139 -0.000269 -7.61E-05 -0.00041 0.047798 0.003108 9.82E-05 -0.00217 0.00020042 
kdegcasp3 -0.00938 -0.00795 -0.00367 0.0070437 0.002413 0.00983 -0.55096 -0.06983 -0.00327 0.055655 -0.0048103 
k11 0.087077 0.05284 0.017985 -0.032774 -0.02081 -0.03545 -1.643 0.200742 0.032956 -0.21957 0.01306423 
k12 -0.00695 -0.00523 -0.0023 0.0043509 0.001747 0.005794 0.433241 -0.03933 -0.00253 0.033079 -0.0027189 
k13 -0.02405 -0.02043 -0.00938 0.0179757 0.006186 0.025037 0.034678 -0.17779 -0.00838 0.142645 -0.0123118 
kdegcasp3a -0.00122 -0.001 -0.00047 0.0008897 0.000312 0.001266 0.001796 -0.0093 -0.00043 0.006983 -0.0006041 
k13 -7.87E-05 -0.01181 -0.00356 3.67E-05 -2.92E-05 0.003599 5.84E-07 -0.96333 -0.00364 0.004952 -0.0690686 
kdegcasp3a -1.74E-08 -5.73E-06 -1.45E-06 1.50E-08 -1.16E-08 1.46E-06 2.71E-10 -0.00028 -1.46E-06 1.94E-06 -2.60E-05 
ksynXIAP -0.00014 0.005149 -9.47E-05 9.76E-07 -9.65E-05 9.38E-05 2.04E-07 -0.02333 0.999977 0.011857 -0.0001659 
kdegXIAP 3.17E-07 0.018047 6.87E-05 -7.08E-07 4.67E-05 -6.99E-05 -4.86E-09 0.01159 -0.0026 -0.00561 0.00031701 
k14 -9.31E-05 -0.02602 -0.00081 8.34E-06 -9.46E-05 0.000822 1.79E-07 -0.01219 -0.90662 0.003656 -0.0049175 
k15 -8.30E-05 0.010693 0.000133 -1.37E-06 6.50E-06 -0.00014 2.82E-08 0.002435 0.955636 -0.00079 0.00093302 
k16 2.40E-07 0.010928 3.91E-05 -4.03E-07 2.77E-05 -3.98E-05 -2.67E-09 0.007617 3.89E-05 -0.00372 0.00017285 
kdegXIAPp 8.59E-07 0.042638 9.76E-05 -1.01E-06 9.30E-05 -9.96E-05 -2.87E-09 0.046449 9.62E-05 -0.02346 0.00034921 
k17 -2.17E-06 0.007861 -0.00014 1.40E-06 2.10E-05 0.000137 3.18E-08 0.035295 -0.00014 -0.0023 0.0808143 
kdegcomplex -1.69E-06 0.006143 -0.00021 2.12E-06 1.29E-05 0.000208 1.16E-08 -0.55915 -0.00021 -0.00402 -0.5808464 
k18 4.68E-06 -0.0288 0.000667 -6.88E-06 -6.96E-05 -0.00067 -6.66E-08 0.379156 0.000672 0.012557 -0.5539025 
n1 -0.00021 -0.05958 -0.0174 0.0001794 -0.00022 0.017622 2.97E-06 -4.66009 -0.01753 0.023891 -0.33188 
n2 -2.24E-07 -0.01255 -3.50E-05 3.61E-07 -3.04E-05 3.56E-05 1.51E-09 -0.01038 -3.46E-05 0.005158 -0.0001338 
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ksynXIAP -0.00011 -0.00188 -7.72E-05 0.0001509 3.15E-05 0.000247 0.000136 -0.00199 0.288494 0.01132 0.00140334 
kdegXIAP 0.000246 0.003908 0.000165 -0.000322 -6.95E-05 -0.00052 -0.00031 0.004127 -0.48606 -0.02144 -0.0028412 
k14 -0.00215 -0.0197 -0.001 0.0019244 0.000568 0.002781 0.002926 -0.02026 -0.27465 0.063772 0.01169509 
k15 6.22E-05 0.001114 4.40E-05 -8.61E-05 -1.78E-05 -0.00014 -7.76E-05 0.001178 0.025461 -0.00739 -0.0008515 
k16 0.012353 0.15237 0.006765 -0.013141 -0.00335 -0.02024 -0.01626 0.156195 0.00411 -0.69047 -0.1037453 
kdegXIAPp 0.000229 0.00261 0.00012 -0.000233 -6.16E-05 -0.00036 -0.0003 0.002711 7.65E-05 -0.01149 -0.0017314 
k17 -0.00383 0.11568 0.000477 -0.001099 0.000803 -0.00321 0.00731 0.032143 -0.00156 -0.43803 0.18265254 
kdegcomplex -0.00135 0.054552 -6.34E-05 8.28E-05 0.000306 -0.0004 0.002217 0.006122 -0.0005 -0.33122 -0.5332121 
k18 0.008719 -0.23905 -0.00209 0.0045801 -0.00173 0.010211 -0.01904 -0.09195 0.003961 0.717198 -0.3184647 
n1 -0.01772 -0.01566 -0.00704 0.013529 0.00457 0.018344 0.024751 -0.12544 -0.00602 0.107914 -0.0092506 
n2 0.034798 0.445439 0.019083 -0.037072 -0.00943 -0.05704 -0.04569 0.441692 0.011536 -1.96764 -0.3065346 
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